20
Informaciones
Psiquiátricas
2015 - n.º 219
Dr. Juan de J. Llibre Rodríguez
27. Ballard C, Gauthier S, Corbett A, Brayne
C, Aarsland D, Jones E. Alzheimer’s di-
sease. Lancet 2011; 377: 1019–31.
28. Meng X, D’Arcy C. Education and Demen-
tia in the Context of the Cognitive Re-
serve Hypothesis: A Systematic Review
with Meta-Analyses and Qualitative
Analyses. PLoS ONE 2012; 7(6): e38268.
doi:10.1371/journal.pone.0038268
29. Deborah E Barnes, Kristine Yaffe .The
projected effect of risk factor reduction
on Alzheimer’s disease prevalence. Lan-
cet Neurol 2011; 10: 819–28
30. Ownby RL, Crocco E, Acevedo A, John
V, Loewenstein D. Depression and risk
for Alzheimer disease: systematic re-
view, meta-analysis, and metaregression
analysis. Arch Gen Psychiatry 2006; 63:
530–38.
31. Reisa S, Keith J. Biomarkers of Alzheimer
Disease: Current and Future Applications
to Diagnostic Criteria. Continuum (Min-
neap Minn) 2013;19(2):325–338.
32. Brodaty H, Breteler M, DeKosky S, Do-
renlot P. The World of Dementia Be-
yond 2020. J Am Geriatr Soc 2011. DOI:
10.1111/j.1532-5415.2011.
33. Panza F, Frisardi V, Solfrizzi V, Imbim-
bo B, Logroscino G, Santamato A, et al.
Immunotherapy for Alzheimer’s disease:
from anti-b amyloid to tau-based immu-
nization strategies. Immunotherapy ;
2012: 4(2), 213–238.
